The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Glycated Albumin Is a Better Glycemic Indicator than Glycated Hemoglobin Values in Hemodialysis Patients with Diabetes: Effect of Anemia and Erythropoietin Injection
Abstract
The significance of glycated albumin (GA), compared with casual plasma glucose (PG) and glycated hemoglobin (HbA(1c)), was evaluated as an indicator of the glycemic control state in hemodialysis (HD) patients with diabetes. The mean PG, GA, and HbA(1c) levels were 164.5 +/- 55.7 mg/dl, 22.5 +/- 7.5%, and 5.85 +/- 1.26%, respectively, in HD patients with diabetes (n = 538), which were increased by 51.5, 31.6, and 17.7%, respectively, compared with HD patients without diabetes (n = 828). HbA(1c) levels were significantly lower than simultaneous PG and GA values in those patients in comparison with the relationship among the three parameters in patients who had diabetes without renal dysfunction (n = 365), as reflected by the significantly more shallow slope of regression line between HbA(1c) and PG or GA. A significant negative correlation was found between GA and serum albumin (r = -0.131, P = 0.002) in HD patients with diabetes, whereas HbA(1c) correlated positively and negatively with hemoglobin (r = 0.090, P = 0.036) and weekly dose of erythropoietin injection (r = -0.159, P < 0.001), respectively. Although PG and GA did not differ significantly between HD patients with diabetes and with and without erythropoietin injection, HbA(1c) levels were significantly higher in patients without erythropoietin. Categorization of glycemic control into arbitrary quartile by HbA(1c) level led to better glycemic control in a significantly higher proportions of HD patients with diabetes than those assessed by GA. Multiple regression analysis demonstrated that the weekly dose of erythropoietin, in addition to PG, emerged as an independent factor associated with HbA(1c) in HD patients with diabetes, although PG but not albumin was an independent factor associated with GA. In summary, it is suggested that GA provides a significantly better measure to estimate glycemic control in HD patients with diabetes and that the assessment of glycemic control by HbA(1c) in these patients might lead to underestimation likely as a result of the increasing proportion of young erythrocyte by the use of erythropoietin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059 · cited 1×
“GA acquires biologic properties that are linked to the pathogenesis of diabetic vascular complications (28,29), suggesting that GA not only is significant as an indicator of hyperglycemia (30,31) but also contributes directly to vascular injury.”
BackgroundTurner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N., & Shichiri, M. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01064-k · Cited by 3,079
Correlation of Glucose Regulation and Hemoglobin AIcin Diabetes Mellitus
Koenig, R. J., Peterson, C. M., Jones, R. L., Saudek, C., Lehrman, M., & Cerami, A. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608192950804 · Cited by 1,175
The Glycosylation of Hemoglobin: Relevance to Diabetes Mellitus
Bunn, H. F., Gabbay, K. H., & Gallop, P. M. (1978) · Science · doi:10.1126/science.635569 · Cited by 876
Pisoni, R. L., Bragg-Gresham, J. L., Young, E. W., Akizawa, T., Asano, Y., Locatelli, F., Bommer, J., Cruz, J. M., Kerr, P. G., Mendelssohn, D. C., et al. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.03.023 · Cited by 391
Avignon, A., Radauceanu, A., & Monnier, L. (1997) · Diabetes Care · doi:10.2337/diacare.20.12.1822 · Cited by 363
Glycemic Control Is a Predictor of Survival for Diabetic Patients on Hemodialysis
Morioka, T., Emoto, M., Tabata, T., Shoji, T., Tahara, H., Kishimoto, H., Ishimura, E., & Nishizawa, Y. (2001) · Diabetes Care · doi:10.2337/diacare.24.5.909 · Cited by 222
Self-citationRed cell age-related changes of hemoglobins AIa+b and AIc in normal and diabetic subjects.
Fitzgibbons, J. F., Koler, R. D., & Jones, R. T. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108534 · Cited by 166
Kouzuma, T., Uemastu, Y., Usami, T., & Imamura, S. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.02.019 · Cited by 163
Long-term glycemic control measurements in diabetic patients receiving hemodialysis
Joy, M. S., Cefalu, W. T., Hogan, S. L., & Nachman, P. H. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.30549 · Cited by 152
Wu, M.-S., Yu, C., Yang, C., Wu, C., Haung, J., Hong, J., Chiang, C., Huang, C., & Leu, M. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.10.2105 · Cited by 138
Nakao, T., Matsumoto, H., OKADA, T., Han, M., Hidaka, H., Yoshino, M., Shino, T., Yamada, C., & Nagaoka, Y. (1998) · Internal Medicine · doi:10.2169/internalmedicine.37.826 · Cited by 132
Cao, J. J., Hudson, M. P., Jankowski, M. A., Whitehouse, F. W., & Weaver, W. D. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.040 · Cited by 101
Glycosylated Serum Protein and Hemoglobin A1 Levels to Measure Control of Glycemia
Kennedy, A. L., & MERIMEE, T. J. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-95-1-56 · Cited by 82
Cohen, M. P., Ziyadeh, F. N., & Chen, S. (2006) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2005.12.006 · Cited by 78
Specific glycation of albumin depends on its half-life
Schleicher, E. D., Olgemöller, B., Wiedenmann, E., & Gerbitz, K.-D. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.4.625 · Cited by 72
Nonenzymatic glycation: A central mechanism in diabetic microvasculopathy?
Cohen, M. P. (1988) · Journal of Diabetes and its Complications · doi:10.1016/s0891-6632(88)80012-6 · Cited by 59
Amore, A., Cirina, P., Conti, G., Cerutti, F., Bagheri, N., Emancipator, S. N., & Coppo, R. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg428 · Cited by 46
Glycemic Monitoring in Diabetics with Sickle Cell Plus β-Thalassemia Hemoglobinopathy
Kosecki, S. M., Rodgers, P. T., & Adams, M. B. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1g010 · Cited by 45
What is the best index of glycemic control in patients with diabetes mellitus on hemodialysis?
Ichikawa, H., Nagake, Y., Takahashi, M., Nakazono, H., Kawabata, K., Shikata, K., & Makino, H. (1996) · PubMed · Cited by 35
Tominaga, M., Makino, H., Yoshino, G., Kuwa, K., Takei, I., Aono, Y., Hoshino, T., Umemoto, M., Shimatsu, A., Sanke, T., et al. (2005) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563053026844 · Cited by 27
Cited by
Human serum albumin: From bench to bedside
Fanali, G., di Masi, A., Trezza, V., Marino, M., Fasano, M., & Ascenzi, P. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.12.002 · Cited by 1,931
KDOQI clinical practice guideline for diabetes and CKD: 2012 update
(2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.07.005 · Cited by 1,320
Diabetic kidney disease: a report from an ADA Consensus Conference
Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1296 · Cited by 1,153
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.08.001 · Cited by 890
Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
Barrett, E. J., Liu, Z., Khamaisi, M., King, G. L., Klein, R., Klein, B. E. K., Hughes, T. M., Craft, S., Freedman, B. I., Bowden, D. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01922 · Cited by 515
Metadata
- Authors
- Inaba, M., Okuno, S., Kumeda, Y., Yamada, S., Imanishi, Y., Tabata, T., Okamura, M., Okada, S., Yamakawa, T., Ishimura, E., & Nishizawa, Y.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2007-03
- Volume
- 18
- Issue
- 3
- Pages
- 896-903
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2114620129
- Cited by
- 493
- References
- 26
- FWCI
- 16.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.